Breast Cancer

MD Newsline Podcast: Now Streaming

Episode 1: Promoting Breast Health Equity   With guest Laura Crandon, Founder and President of Touch4Life   Transcript: [00:00] LC: “So really to take what some would call a tragedy given my metastatic condition and take that and turn it into a triumph so other people can learn from what I’ve been through.” LW: Hello,...

Disparities in Race and Treatment Venues in Breast Cancer Care

The place of care—whether a hospital or a doctor’s office—may have a profound impact on the quality and type of breast cancer care, as well as the reported side effects. One study reports disparities in breast cancer treatments and side effects between African American and White women. White women experience breast cancer more frequently, but...

Distinct Epigenetic Profiles in Younger African American Triple-Negative Breast Cancer Patients

Clinical disparities are apparent in aggressive triple-negative breast cancer based on age and ethnicity. A recent study identifies unique epigenetic differences in triple-negative breast cancer tumors among younger African American women, suggesting potential clinical implications for diagnostics and treatment approaches. Younger African American women with triple-negative breast cancer exhibit distinct DNA methylation profiles. The unique...

MicroRNA's Role in Breast Cancer Tumor Growth and Mortality Disparities

Research reveals potential biological factors contributing to racial disparities in breast cancer mortality rates. MicroRNA-510-5p’s interaction with the scaffolding protein caveolin-1, specifically, could drive aggressive tumor growth and highlight potential reasons behind racial disparities in breast cancer outcomes. miR-510-5p’s regulation of caveolin-1 in fibroblasts potentially fuels aggressive tumor growth. Black women with breast cancer show...

Axillary Ultrasound for Predicting Response to Neoadjuvant Treatment in Breast Cancer

Staff Writer: Andre McGowan A retrospective study found that axillary ultrasound falsely predicted nodal response to neoadjuvant systemic treatment in approximately half of node-positive breast cancer patients, which may result in the overtreatment of breast cancer patients. However, the interpretation of axillary ultrasound in luminal human epidermal growth factor receptor 2 negative cancer is useful...

Cell-Free DNA as a Diagnostic Biomarker in Breast Cancer Patients

Staff Writer: Andre McGowan Cell-free DNA is reported to be an authentic diagnostic biomarker in breast cancer patients. A recent study supports this, noting significantly increased levels of cell-free DNA in a group of breast cancer patients. Increased levels of cell-free deoxyribose nucleic acid (cfDNA) in cancer cells are associated with a reduction in the...

Diet, Exercise Intervention May Aid Chemotherapy Outcomes in Breast Cancer

Staff Writer: Andre McGowan Although relative dose intensity similar, pathologic complete response higher with intervention A home-based diet and exercise intervention could improve outcomes for women undergoing chemotherapy for breast cancer, according to a study published online Sept. 1 in the Journal of Clinical Oncology. Tara Sanft, M.D., from Yale University in New Haven, Connecticut, and...

Diagnostic Performance of AI Comparable to Humans for Mammograms

Diagnostic performance comparable for two test sets from the Personal Performance in Mammographic Screening scheme. Diagnostic performance of an artificial intelligence (AI) algorithm is comparable to human reader performance for interpreting mammographic screening, according to a study published online Sept. 5 in Radiology. Yan Chen, Ph.D., from the University of Nottingham in the United Kingdom,...

Alcohol Linked to Lower Breast Cancer Mortality in Women With Obesity

Possible higher risk of recurrence in association with drinking seen for women with lower body mass index. For women with breast cancer with higher body mass index (BMI), alcohol drinking is associated with a lower risk of overall mortality, according to a study published online Aug. 9 in Cancer. Marilyn L. Kwan, Ph.D., from Kaiser...
<< >>

Categories

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.